BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22739410)

  • 1. Lipid-lowering effect of berberine in human subjects and rats.
    Hu Y; Ehli EA; Kittelsrud J; Ronan PJ; Munger K; Downey T; Bohlen K; Callahan L; Munson V; Jahnke M; Marshall LL; Nelson K; Huizenga P; Hansen R; Soundy TJ; Davies GE
    Phytomedicine; 2012 Jul; 19(10):861-7. PubMed ID: 22739410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice.
    Hu Y; Davies GE
    Fitoterapia; 2010 Jul; 81(5):358-66. PubMed ID: 19861153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver.
    Zhou JY; Zhou SW
    Fitoterapia; 2011 Mar; 82(2):184-9. PubMed ID: 20828602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
    Zhou X; Ren F; Wei H; Liu L; Shen T; Xu S; Wei J; Ren J; Ni H
    Lipids Health Dis; 2017 Dec; 16(1):239. PubMed ID: 29228954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine acutely inhibits the digestion of maltose in the intestine.
    Li ZQ; Zuo DY; Qie XD; Qi H; Zhao MQ; Wu YL
    J Ethnopharmacol; 2012 Jul; 142(2):474-80. PubMed ID: 22626925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism.
    Zhang XJ; Deng YX; Shi QZ; He MY; Chen B; Qiu XM
    Phytomedicine; 2014 Apr; 21(5):615-23. PubMed ID: 24368167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model.
    Yang W; She L; Yu K; Yan S; Zhang X; Tian X; Ma S; Zhang X
    Mol Med Rep; 2016 Oct; 14(4):3277-84. PubMed ID: 27573054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures.
    Ikarashi N; Tajima M; Suzuki K; Toda T; Ito K; Ochiai W; Sugiyama K
    Phytother Res; 2012 Jan; 26(1):91-100. PubMed ID: 21557367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advance on study in anti-atherosclerosis mechanism of berberine].
    Wu M; Wang J
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2013-6. PubMed ID: 19160773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet.
    Xia W; Sun C; Zhao Y; Wu L
    Phytomedicine; 2011 Apr; 18(6):516-20. PubMed ID: 21036582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction.
    Zhao HL; Sim JS; Shim SH; Ha YW; Kang SS; Kim YS
    Int J Obes (Lond); 2005 Aug; 29(8):983-90. PubMed ID: 15852049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TG accumulation inhibitory effects of Jinqi formula by AMPK signaling pathway.
    Qian Q; Liu X; He W; An Y; Chen Q; Wu J; Deng Y; Guo L; Zhang Y; Wang T
    J Ethnopharmacol; 2012 Aug; 143(1):41-8. PubMed ID: 22743057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidative and lipid lowering effects of 7,8-dihydroxy-3- (4-methylphenyl) coumarin in hyperlipidemic rats.
    Yuce B; Danis O; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2009; 59(3):129-34. PubMed ID: 19402343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome.
    Tan Y; Kamal MA; Wang ZZ; Xiao W; Seale JP; Qu X
    Clin Sci (Lond); 2011 Apr; 120(7):297-305. PubMed ID: 20950275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aqueous extract of Gleditsia sinensis Lam. fruits improves serum and liver lipid profiles and attenuates atherosclerosis in rabbits fed a high-fat diet.
    Lai P; Du JR; Zhang MX; Kuang X; Li YJ; Chen YS; He Y
    J Ethnopharmacol; 2011 Oct; 137(3):1061-6. PubMed ID: 21718773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
    Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
    Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity.
    Cao ZH; Gu DH; Lin QY; Xu ZQ; Huang QC; Rao H; Liu EW; Jia JJ; Ge CR
    Phytother Res; 2011 Feb; 25(2):234-8. PubMed ID: 20641056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats.
    Tang LQ; Wei W; Chen LM; Liu S
    J Ethnopharmacol; 2006 Nov; 108(1):109-15. PubMed ID: 16759828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
    Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
    Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
    Zhou J; Zhou S
    Eur J Pharmacol; 2010 Dec; 649(1-3):390-7. PubMed ID: 20868663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.